MED13 siRNA (Mouse)
SiRNA to inhibit MED13 expression using RNA interference
Product Specifications
Product Name Alternative
KIAA0593; THRAP1; TRAP240; Mediator of RNA polymerase II transcription subunit 13; Thyroid hormone receptor-associated protein 1; Thyroid hormone receptor-associated protein complex 240 kDa component; Trap240
Reactivity
M
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of mouse MED13 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
MED13 siRNA (Mouse) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
MED13
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Mouse)
Q5SWW4
Entrez Gene Mouse
327987
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M2342-01A 100 µg
MAP 1 (Modulator of Apoptosis, MOAP1, Modulator of Apoptosis 1, Paraneoplastic Antigen MA4, PNMA4) discontinued, see M2342
Sign In for Pricing
View Details 
